Kumar, A.S. and Samuel, V. 2025. Cost-Effectiveness of Co-Amoxiclav Versus Clindamycinin the Treatment of Uncomplicated Soft Tissue Infections in a Tertiary Care Hospital. Journal of Health and Technology. 1, 1 (Mar. 2025), 15–22.